Postoperative Thallium-201 myocardial imaging predicted graft patency, with 87% of grafts patent in patients with no new perfusion defects compared to 54% in those with new defects (P<0.03).
Observational (n=20)
Does Thallium-201 myocardial imaging predict graft closure and regional perfusion in patients undergoing coronary artery bypass grafting?
Thallium-201 myocardial imaging before and after CABG can noninvasively predict graft closure and assess improved regional perfusion.
Tasa de eventos absoluta: 87% vs 54%
valor p: p=<0.03
Twenty patients underwent myocardial imaging with Thallium-201 (201Tl) before and subsequent to coronary artery bypass grafting. All patients had rest and maximal treadmill exercise imaging postoperatively. Eleven of the 20 patients had rest and exercise 201Tl images preoperatively; 9/20 only had rest imaging preoperatively. Postoperative regional exercise perfusion was improved in seven of the 11 patients who had preoperative exercise images, and was associated with regional graft patency in each case. Thirteen of 20 patients showed no new defect with postoperative exercise imaging. The remaining seven patients developed or had an increased defect with exercise. The patients with no new perfusion defects during postoperative study has 26/30 grafts patent (87%). Patients developing a new perfusion defect with exercise had fewer grafts patent (7 of 13 54%; P less than 0.03). In these seven cases, a new exercise-induced defect was associated with regional graft closure or residual nonoperated disease. Knowledge of the preoperative coronary anatomy allowed the distinction between ungrafted areas and regional graft dysfunction. We conclude that preoperative and postoperative 201Tl imaging may noninvasively predict graft closure and/or improved regional perfusion with patent grafts.
Ritchie et al. (Tue,) conducted a observational in Coronary artery disease requiring bypass grafting (n=20). Thallium-201 myocardial imaging was evaluated on Graft patency (p=<0.03). Postoperative Thallium-201 myocardial imaging predicted graft patency, with 87% of grafts patent in patients with no new perfusion defects compared to 54% in those with new defects (P<0.03).